{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T20:15:53Z","timestamp":1791490553015,"version":"4.3.4"},"reference-count":24,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T00:00:00Z","timestamp":1684800000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Emory University's Open Access Publishing Fund\u00a0"},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,6,1]]},"abstract":"<jats:p>We describe the successful use of the novel antifungal drug fosmanogepix to treat a chronic case of multidrug-resistant cutaneous Fusarium suttonianum infection in a pediatric patient with STAT3 hyper-IgE syndrome and end-stage kidney disease on peritoneal dialysis.<\/jats:p>","DOI":"10.1093\/ofid\/ofad285","type":"journal-article","created":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T22:35:39Z","timestamp":1684881339000},"source":"Crossref","is-referenced-by-count":15,"title":["Successful Use of Fosmanogepix for Treatment of Rare Highly Resistant Cutaneous Fusariosis in a Pediatric Patient With STAT3 Hyper-Immunoglobulin E Syndrome and End-Stage Kidney Disease"],"prefix":"10.1093","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-0460-937X","authenticated-orcid":false,"given":"Kathryn P","family":"Goggin","sequence":"first","affiliation":[{"name":"Division of Infectious Diseases, Department of Pediatrics, Emory University School of Medicine and Children\u2019s Healthcare of Atlanta , Atlanta, Georgia , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jackson","family":"Londeree","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Pediatrics, Emory University School of Medicine and Children\u2019s Healthcare of Atlanta , Atlanta, Georgia , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra F","family":"Freeman","sequence":"additional","affiliation":[{"name":"Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health , Bethesda, Maryland , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rouba","family":"Garro","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Pediatrics, Emory University School of Medicine and Children\u2019s Healthcare of Atlanta , Atlanta, Georgia , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roshan P","family":"George","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Pediatrics, Emory University School of Medicine and Children\u2019s Healthcare of Atlanta , Atlanta, Georgia , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,5,23]]},"reference":[{"key":"2023060811340280100_ofad285-B1","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s10875-022-01404-4","article-title":"Primary invasive cutaneous fusariosis in patients with STAT3 hyper-IgE syndrome","volume":"43","author":"Abbara","year":"2023","journal-title":"J Clin Immunol"},{"key":"2023060811340280100_ofad285-B2","first-page":"35","article-title":"Multimodal therapy for recalcitrant cutaneous Fusarium solani infection in a patient with hyper-IgE syndrome","volume":"1","author":"Belcher","year":"2017","journal-title":"Dermatol Arch"},{"key":"2023060811340280100_ofad285-B3","doi-asserted-by":"crossref","first-page":"e383","DOI":"10.1016\/S1473-3099(17)30316-X","article-title":"The global problem of antifungal resistance: prevalence, mechanisms, and management","volume":"17","author":"Perlin","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"2023060811340280100_ofad285-B4","doi-asserted-by":"crossref","DOI":"10.1590\/0037-8682-0013-2020","article-title":"Human fusariosis: an emerging infection that is difficult to treat","volume":"53","author":"Batista","year":"2020","journal-title":"Rev Soc Bras Med Trop"},{"key":"2023060811340280100_ofad285-B5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.idc.2015.10.004","article-title":"The global burden of fungal diseases","volume":"30","author":"Vallabhaneni","year":"2016","journal-title":"Infect Dis Clin North Am"},{"key":"2023060811340280100_ofad285-B6","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3390\/jof3020019","article-title":"Antifungal susceptibility testing of fusarium: a practical approach","volume":"3","author":"Al-Hatmi","year":"2017","journal-title":"J Fungi (Basel)"},{"key":"2023060811340280100_ofad285-B7","doi-asserted-by":"crossref","first-page":"239","DOI":"10.3390\/jof6040239","article-title":"Fosmanogepix: a review of the first-in-class broad spectrum agent for the treatment of invasive fungal infections","volume":"6","author":"Shaw","year":"2020","journal-title":"J Fungi (Basel)"},{"key":"2023060811340280100_ofad285-B8","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofaa016","article-title":"Hope on the horizon: novel fungal treatments in development","volume":"7","author":"Rauseo","year":"2020","journal-title":"Open Forum Infect Dis"},{"key":"2023060811340280100_ofad285-B9","doi-asserted-by":"crossref","DOI":"10.1128\/aac.01028-22","article-title":"Activities of manogepix and comparators against 1,435 recent fungal isolates collected during an international surveillance program (2020)","volume":"66","author":"Pfaller","year":"2022","journal-title":"Antimicrob Agents Chemother"},{"key":"2023060811340280100_ofad285-B10","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1093\/cid\/ciab1070","article-title":"Investigational antifungal agents for invasive mycoses: a clinical perspective","volume":"75","author":"Lamoth","year":"2022","journal-title":"Clin Infect Dis"},{"key":"2023060811340280100_ofad285-B11","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01795-20","article-title":"Efficacy and pharmacokinetics of fosmanogepix (APX001) in the treatment of Candida endophthalmitis and hematogenous meningoencephalitis in nonneutropenic rabbits","volume":"65","author":"Petraitiene","year":"2021","journal-title":"Antimicrob Agents Chemother"},{"key":"2023060811340280100_ofad285-B12","year":"2022"},{"key":"2023060811340280100_ofad285-B13","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1056\/NEJMra1216008","article-title":"Mold infections of the central nervous system","volume":"371","author":"McCarthy","year":"2014","journal-title":"N Engl J Med"},{"key":"2023060811340280100_ofad285-B14","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1128\/AAC.02456-15","article-title":"International evaluation of MIC distributions and epidemiological cutoff value (ECV) definitions for Fusarium species identified by molecular methods for the CLSI broth microdilution method","volume":"60","author":"Espinel-Ingroff","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"2023060811340280100_ofad285-B15","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02343-20","article-title":"Manogepix, the active moiety of the investigational agent fosmanogepix, demonstrates in vitro activity against members of the Fusarium oxysporum and Fusarium solani species complexes","volume":"65","author":"Badali","year":"2021","journal-title":"Antimicrob Agents Chemother"},{"key":"2023060811340280100_ofad285-B16","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1128\/AAC.05414-11","article-title":"Activities of E1210 and comparator agents tested by CLSI and EUCAST broth microdilution methods against Fusarium and Scedosporium species identified using molecular methods","volume":"56","author":"Castanheira","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"2023060811340280100_ofad285-B17","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.idc.2018.04.006","article-title":"Mold infections in solid organ transplant recipients","volume":"32","author":"Lemonovich","year":"2018","journal-title":"Infect Dis Clin North Am"},{"key":"2023060811340280100_ofad285-B18","doi-asserted-by":"crossref","DOI":"10.1111\/tid.12872","article-title":"Fatal Fusarium infection manifesting as osteomyelitis following previous treatment with amphotericin B in a multi-visceral transplant: case report and review of Fusarium infections in solid organ transplantation","volume":"20","author":"Nambiar","year":"2018","journal-title":"Transpl Infect Dis"},{"key":"2023060811340280100_ofad285-B19","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1128\/CMR.00014-07","article-title":"Fusarium infections in immunocompromised patients","volume":"20","author":"Nucci","year":"2007","journal-title":"Clin Microbiol Rev"},{"key":"2023060811340280100_ofad285-B20","doi-asserted-by":"crossref","first-page":"3623","DOI":"10.1128\/JCM.41.8.3623-3626.2003","article-title":"Activities of caspofungin, itraconazole, posaconazole, ravuconazole, voriconazole, and amphotericin B against 448 recent clinical isolates of filamentous fungi","volume":"41","author":"Diekema","year":"2003","journal-title":"J Clin Microbiol"},{"key":"2023060811340280100_ofad285-B21","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1128\/AAC.50.3.917-921.2006","article-title":"Head-to-head comparison of the activities of currently available antifungal agents against 3,378 Spanish clinical isolates of yeasts and filamentous fungi","volume":"50","author":"Cuenca-Estrella","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"2023060811340280100_ofad285-B22","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1111\/myc.13273","article-title":"In vitro activity of olorofim against clinical isolates of the Fusarium oxysporum and Fusarium solani species complexes","volume":"64","author":"Badali","year":"2021","journal-title":"Mycoses"},{"key":"2023060811340280100_ofad285-B23","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/1346-8138.15168","article-title":"Cutaneous fusariosis caused by Fusarium lichenicola in a child with hyper-immunoglobulin E syndrome","volume":"47","author":"Shi","year":"2020","journal-title":"J Dermatol"},{"key":"2023060811340280100_ofad285-B24","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1056\/NEJMoa2117028","article-title":"Sequential stem cell-kidney transplantation in Schimke immuno-osseous dysplasia","volume":"386","author":"Bertaina","year":"2022","journal-title":"N Engl J Med"}],"container-title":["Open Forum Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ofid\/advance-article-pdf\/doi\/10.1093\/ofid\/ofad285\/50424829\/ofad285.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/10\/6\/ofad285\/50539174\/ofad285.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/10\/6\/ofad285\/50539174\/ofad285.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,8]],"date-time":"2023-06-08T11:34:34Z","timestamp":1686224074000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ofid\/article\/doi\/10.1093\/ofid\/ofad285\/7176278"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,23]]},"references-count":24,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ofid\/ofad285","relation":{},"ISSN":["2328-8957"],"issn-type":[{"value":"2328-8957","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,6]]},"published":{"date-parts":[[2023,5,23]]},"article-number":"ofad285"}}